Latest Reports

Market Scope uses a multi-source methodology when preparing our annual and quarterly reports. We incorporate surgeon surveys, our extensive database of physicians and surgery centers, disease models, clinical studies, financial reports, and more. Our wide-ranging knowledge of products and technology and our comprehensive network of industry contacts also contribute to our coverage on the ophthalmic industry.

FEATURED

2022 IOL Market Report: Global Analysis for 2021 to 2027, April, 2022

The “2022 IOL Market Report” provides an in-depth analysis of the current intraocular lens market and forecasts performance over the next five years. It includes analysis of current markets, identification of important trends, and discussion of key factors for future success. 

This report describes and forecasts performance by region for 11 categories of IOLs: commodity monofocal, enhanced monofocal/intermediate-optimized monofocal, toric, PC-toric, bifocal, trifocal, extended depth of focus (EDOF), EDOF multifocal hybrid, accommodating, postoperatively adjustable, and phakic IOLs.

2021 Fundus Imaging Market Report: Global Analysis for 2020 to 2026, May, 2022

The “2021 Fundus Imaging Market Report” is a specialized supplement, expanding on the fundus imaging section of Market Scope’s comprehensive, global “2021 Ophthalmic Diagnostic Equipment Market Report.”

The report provides background information about fundus imaging devices and divides estimates into four categories: fundus screeners, diagnostic fundus imaging, advanced fundus imaging, and combination systems. Estimates include unit sales, installed equipment base, average prices, and information about the manufacturers that participate in the market.

2022 United States Glaucoma Atlas Featuring the Market Scope Exclusive MedOp Index™ Analysis, May, 2022

The “2022 United States Glaucoma Atlas” provides a geographic analysis of the glaucoma population and treatment opportunity in 85 US metropolitan areas. Market Scope’s proprietary MedOp Index Analysis™ analyzes market potential and provides a benchmark against other atlas metros. The atlas offers strategic insights into the top potential markets in the US, which companies often use throughout the development and commercialization processes to identify ideal clinical trial locations, develop launch strategies, define sales territories, allocate resources, and optimize sales and marketing initiatives.

2022 China Ophthalmic Market Report: Regional Analysis for 2021 to 2027, May, 2022

The “2022 China Ophthalmic Market Report” is the leading industry source for accurate and relevant information on all aspects of China’s ophthalmic market. This report provides a comprehensive overview of the Chinese population and economic conditions. It also covers disease prevalence and therapeutic approaches, including commercialized and pipeline products. The report analyzes unit demand and revenue, and it forecasts future performance over the next five years. It also includes market share data and discusses key strategic issues. Additionally, 31 market competitors are profiled, with discussion of their products, strategic market position, background, and outlook.

2022 India Ophthalmic Market Report: Regional Analysis for 2020 to 2027, April, 2022

The “2022 India Ophthalmic Market Report” analyzes the current landscape of the Indian ophthalmic market, discussing important trends and key factors for future success, and includes forecasts of disease prevalence, numbers of treatments, and technologies used in treatments. The report analyzes the Indian markets for diagnostic equipment, lasers, cataract, refractive, cornea, glaucoma, retina, dry eye, surgical instruments, and single-use surgical devices. Thirty market competitors are profiled, with discussion of their products, strategic market positions, background, and outlook.

Ophthalmic Market Perspectives Monthly Newsletter

April, 2022

Market Scope has published the Ophthalmic Market Perspectives (OMP) newsletter for more than 20 years. The newsletter provides the latest business information that is shaping ophthalmic markets and professions. Our articles explore new technologies and company developments. We offer opinions on issues facing the industry. We also analyze and chart quarterly industry data, and we forecast market performance over time.

US Cataract Quarterly Update

Q1 - 2022

Our coverage of the cataract surgery market includes a quarterly surveying process that targets and collects data from US cataract surgeons. The resulting data are analyzed and presented in our US Cataract Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

US Refractive Quarterly Update

Q1 - 2022

Our coverage of the refractive surgery market includes a quarterly surveying process that targets and collects data from US refractive surgeons. The resulting data are analyzed and presented in our US Refractive Surgery Quarterly Updates. These updates are designed to improve your decision-making process with the most accurate assessment of current market conditions and the identification of significant market trends. 

US Glaucoma Quarterly Update

Q1 - 2022

Our coverage of the US glaucoma surgery market includes a quarterly surveying process that targets and collects data from glaucoma surgeons. The resulting data are analyzed and presented in our US Glaucoma Surgery Quarterly Updates. These updates are designed to improve your decision-making process with an assessment of current market conditions and the identification of significant market trends -- including a variety of vital practice of medicine issues, doctors’ evaluations of pharmaceuticals and surgical equipment, product use and market share, product adoption plans, and the identification of significant trends in the marketplace for the treatment of glaucoma. 

Each update includes full-year forecasts, comparisons with prior years, and trend analysis.

Ophthalmic Deals Report

Q1, 2022

The “Ophthalmic Deals Report” analyzes recent investments in ophthalmology and provides information for evaluation of the market value of various technologies, as evidenced by investment amounts and sales prices for new ophthalmic ventures.

This report covers recent investments in ophthalmic ventures, including venture capital, public offerings, licensing, milestone payments, sales of products and companies, and major borrowings. The report is designed for entrepreneurs, investors, venture capitalists, and companies looking to invest in the ophthalmic market—and companies looking to raise funds.

Want to Purchase the Full Report?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more